Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients
Clinical trial NCT06095375 · COMPLETED
Trial details
- NCT number
- NCT06095375
- Sponsor
- Istituto Oncologico Veneto IRCCS
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-04
- Primary completion
- 2024-10-09
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.